Therefore, a stimulation of HIF-1α via liver ischemia, could be a double-edged sword; i.e., it protects the liver against I/R injuries, but a side effect could be the promotion of recurrence and metastasis of HCC through angiogenesis. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.